Science
Mechanism of Action
This peptide acts as a specific antagonist to Bone Morphogenetic Proteins (BMP-2 and BMP-4), which naturally signal the skin and scalp to halt growth. By neutralizing these inhibitory signals, it facilitates the transition of hair follicles into the active growth phase and stimulates keratinocyte proliferation to increase epidermal thickness.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 In-vitro analysis confirms Noggin-mimetic activity successfully initiates the anagen growth phase in resting hair follicles by inhibiting BMP-4.
- 02 A 12-week clinical evaluation of topical recombinant Noggin demonstrated a measurable increase in hair density and a significant reduction in shedding.
Transparency
Dusting Analysis
Due to its high cost and potency (effective at parts per million), brands often include this ingredient at trace levels far below the 0.5% concentration used in clinical evaluations to claim its benefits.
The Formula
Formulation
Stability
Thermolabile protein; must be incorporated during the cooling phase below 40°C. Avoid high-shear processing to maintain protein tertiary structure.
Synergies
- Hyaluronic acid
- Buffered aqueous solutions
- Other growth factor mimetics
Conflicts
- Proteolytic enzymes (Papain, Bromelain)
- Strong acids (pH < 4.0)
- High ethanol concentrations
- Aggressive surfactants
Safety
Safety Profile
Highly biocompatible recombinant protein; barley-derived extracts are traditionally recognized as safe in cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An elite signaling peptide for regenerative formulas, particularly effective for scalp health and age-defying skin thickness when used at functional concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources